Alivus Life Sciences Ltd., incorporated in the year 2011, is a Small Cap company (having a market cap of Rs 12,698.51 Crore) operating in Pharmaceuticals sector. Alivus Life Sciences Ltd. key Products ...

Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per share.

Halozyme claims Merck infringed on patents in developing a subcutaneous form of Keytruda. Elsewhere, Vanda’s challenge to an ...

Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment ...

The transaction, which sources say could be agreed upon as soon as Monday, would price SpringWorks at $47 per share, totaling ...

Merck KGaA’s protracted pursuit of SpringWorks Therapeutics may be nearing its endgame. | Merck KGaA’s protracted pursuit of ...

Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 ...

an astrobiologist at RISE Research Institutes of Sweden who also works on the Mars Perseverance science team. “Because one important question is if there was life, when was the delta active and ...

This is an extraordinary technological leap in genetic engineering efforts for both science and for conservation as well as preservation of life, and a wonderful example of the power of ...

A fascinating new study has revealed that there could in fact be life on the Moon. Although not yet peer-reviewed, the new findings have outlined the idea that microbes could be thriving in ...